XenoPort, Inc. (XNPT) Now Covered by Credit Suisse
Research analysts at Credit Suisse started coverage on shares of XenoPort, Inc. (NASDAQ:XNPT) in a research report issued to clients and investors on Tuesday, Market Beat Ratings reports. The brokerage set an "underperform" rating and a $4.00 price target on the biopharmaceutical company's stock. Credit Suisse's price target points to a potential downside of 16.49% [...]
Friday, January 22, 2016
Why $XNPT is UP 5% #AHtrading @ $5.05 ?
Subscribe to:
Post Comments (Atom)
Powered By
Find Out MORE
No comments:
Post a Comment